Natural Alternatives International (NAII) Financials

$2.22 -0.04 (-1.77%)

Closing price 07/17/2026 04:00 PM Eastern

Extended Trading

$2.22 +0.00 (+0.23%)

As of 07/17/2026 04:10 PM Eastern

Annual Income Statements for Natural Alternatives International

This table shows Natural Alternatives International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	3.35	9.55	7.24	5.05	6.54	-1.65	11	13	2.52	-7.22	-14
Consolidated Net Income / (Loss)	3.35	9.55	7.24	5.05	6.54	-1.65	11	11	2.52	-7.22	-14
Net Income / (Loss) Continuing Operations	3.35	9.55	7.24	5.05	6.54	-1.65	11	11	2.52	-7.22	-14
Total Pre-Tax Income	4.31	14	10	11	7.95	-1.74	12	14	3.56	-9.46	-11
Total Operating Income	4.16	12	9.70	9.53	5.96	-1.51	14	14	4.71	-8.53	-8.66
Total Gross Profit	14	25	26	26	24	19	30	31	18	6.87	9.29
Total Revenue	80	114	122	132	138	119	179	171	154	114	130
Operating Revenue	80	114	122	132	138	119	179	171	154	114	130
Total Cost of Revenue	65	89	96	106	115	100	148	140	136	107	121
Operating Cost of Revenue	65	89	96	106	115	100	148	140	136	107	121
Total Operating Expenses	10	13	17	17	18	20	17	17	13	15	18
Selling, General & Admin Expense	10	13	17	17	18	17	17	17	15	15	17
Other Special Charges / (Income)	-	-	-	-	-	-	-	-	-	0.00	1.40
Total Other Income / (Expense), net	0.15	1.31	0.41	1.08	1.99	-0.23	-1.55	-0.04	-1.16	-0.93	-2.08
Interest Expense	0.01	-0.00	0.00	0.01	0.03	0.07	0.12	0.08	0.45	0.36	0.92
Interest & Investment Income	0.04	0.13	0.46	1.09	1.87	0.18	0.00	0.00	0.03	0.18	0.17
Other Income / (Expense), net	0.12	1.18	-0.05	0.00	0.15	-0.34	-1.43	0.04	-0.74	-0.75	-1.33
Income Tax Expense	0.96	4.03	2.88	5.56	1.41	-0.09	1.36	2.95	1.03	-2.25	2.84
Basic Earnings per Share	$0.50	$1.46	$1.10	$0.76	$0.96	($0.25)	$1.71	$1.75	$0.43	($1.23)	($2.28)
Weighted Average Basic Shares Outstanding	6.75M	6.52M	6.58M	6.64M	6.81M	6.70M	6.29M	6.12M	5.86M	5.87M	5.95M
Diluted Earnings per Share	$0.49	$1.44	$1.09	$0.73	$0.92	($0.25)	$1.69	$1.74	$0.43	($1.23)	($2.28)
Weighted Average Diluted Shares Outstanding	6.81M	6.64M	6.66M	6.89M	7.10M	6.70M	6.38M	6.16M	5.88M	5.87M	5.95M
Weighted Average Basic & Diluted Shares Outstanding	6.71M	6.87M	7.44M	7.56M	7.23M	6.52M	6.43M	6.09M	6.09M	6.20M	6.18M

This table shows Natural Alternatives International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-0.70	-3.07	-1.46	-1.99	-1.98	-2.19	-2.19	-7.22	-0.29	-2.55	-4.31
Consolidated Net Income / (Loss)	-0.70	-3.07	-1.58	-1.87	-1.98	-2.19	-2.19	-7.22	-0.29	-2.55	-4.31
Net Income / (Loss) Continuing Operations	-0.70	-3.07	-1.58	-1.87	-1.98	-2.19	-2.19	-7.22	-0.29	-2.55	-4.31
Total Pre-Tax Income	-0.88	-3.83	-1.97	-2.78	-2.41	-2.87	-2.64	-2.82	-0.20	-2.33	-4.24
Total Operating Income	-0.54	-3.51	-1.95	-2.53	-1.84	-2.78	-2.10	-1.94	0.28	-1.85	-4.01
Total Gross Profit	3.14	0.39	1.92	1.42	2.26	1.67	1.83	3.54	4.40	2.49	0.38
Total Revenue	34	25	25	29	33	34	29	34	38	35	35
Operating Revenue	34	25	25	29	33	34	29	34	38	35	35
Total Cost of Revenue	31	25	23	28	31	32	27	30	33	32	35
Operating Cost of Revenue	31	25	23	28	31	32	27	30	33	32	35
Total Operating Expenses	3.68	3.90	3.87	3.94	4.10	4.45	3.93	5.48	4.11	4.34	4.40
Selling, General & Admin Expense	3.68	3.90	3.87	3.94	4.10	4.45	3.93	4.08	4.11	4.34	4.40
Total Other Income / (Expense), net	-0.34	-0.32	-0.03	-0.24	-0.58	-0.09	-0.54	-0.88	-0.48	-0.48	-0.23
Interest Expense	0.09	0.07	0.07	0.12	0.18	0.28	0.25	0.21	0.23	0.22	0.27
Interest & Investment Income	0.01	0.01	0.08	0.08	0.03	0.04	0.05	0.04	0.03	0.00	0.00
Other Income / (Expense), net	-0.26	-0.26	-0.04	-0.19	-0.43	0.15	-0.35	-0.71	-0.29	-0.26	0.04
Income Tax Expense	-0.19	-0.76	-0.39	-0.91	-0.43	-0.68	-0.46	4.40	0.09	0.22	0.07
Basic Earnings per Share	($0.12)	($0.52)	($0.27)	($0.32)	($0.33)	($0.37)	($0.37)	($1.21)	($0.05)	($0.42)	($0.72)
Weighted Average Basic Shares Outstanding	5.85M	5.85M	5.87M	5.87M	5.92M	5.92M	5.94M	5.95M	6.01M	6.01M	6.03M
Diluted Earnings per Share	($0.12)	($0.52)	($0.27)	($0.32)	($0.33)	($0.37)	($0.37)	($1.21)	($0.05)	($0.42)	($0.72)
Weighted Average Diluted Shares Outstanding	5.85M	5.85M	5.87M	5.87M	5.92M	5.92M	5.94M	5.95M	6.01M	6.01M	6.03M
Weighted Average Basic & Diluted Shares Outstanding	6.09M	6.09M	3.28M	6.20M	6.20M	6.20M	6.18M	6.18M	6.18M	6.18M	6.28M

This table details how cash moves in and out of Natural Alternatives International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	-0.96	1.20	8.10	-4.23	1.43	5.44	1.66	-10	-8.23	-1.62	0.34
Net Cash From Operating Activities	2.68	9.29	14	1.83	6.56	3.69	21	12	7.02	-1.50	5.93
Net Cash From Continuing Operating Activities	2.68	9.29	14	1.83	6.56	3.69	21	12	7.02	-1.50	5.93
Net Income / (Loss) Continuing Operations	3.35	9.55	7.24	5.05	6.54	-1.65	11	11	2.52	-7.22	-14
Consolidated Net Income / (Loss)	3.35	9.55	7.24	5.05	6.54	-1.65	11	11	2.52	-7.22	-14
Depreciation Expense	2.43	1.77	2.38	2.91	3.47	3.96	4.34	4.17	4.25	4.65	4.56
Non-Cash Adjustments To Reconcile Net Income	0.78	-1.03	1.25	1.86	1.86	5.44	1.59	0.66	0.32	4.33	5.53
Changes in Operating Assets and Liabilities, net	-3.88	-1.01	3.27	-7.99	-5.30	-4.06	4.11	-3.68	-0.07	-3.25	9.42
Net Cash From Investing Activities	-1.62	-7.44	-5.33	-5.55	-3.81	-4.51	-5.04	-26	-13	-3.02	-3.61
Net Cash From Continuing Investing Activities	-1.62	-7.44	-5.33	-5.55	-3.81	-4.51	-5.04	-26	-13	-3.02	-3.61
Purchase of Property, Plant & Equipment	-1.71	-10	-5.35	-4.08	-5.33	-4.54	-5.11	-26	-14	-3.02	-3.61
Net Cash From Financing Activities	-2.02	-0.65	-0.71	-0.51	-1.33	6.25	-14	4.29	-1.78	2.89	-1.97
Net Cash From Continuing Financing Activities	-2.02	-0.65	-0.71	-0.51	-1.33	6.25	-14	4.29	-1.78	2.89	-1.97
Repayment of Debt	-	-	-	-	-	-	0.00	-0.21	-0.28	-0.29	-0.30
Repurchase of Common Equity	-2.02	-0.65	-0.71	-0.51	-1.37	-3.75	-4.15	-5.50	-1.50	-0.22	-0.18
Issuance of Debt	-	-	-	-	0.00	10	-10	10	0.00	3.40	-1.50
Cash Interest Paid	0.01	0.00	0.00	0.01	0.02	0.07	0.13	0.21	0.80	0.29	0.81
Cash Income Taxes Paid	0.89	3.36	2.89	1.82	1.97	0.99	2.96	2.61	1.84	0.46	0.32

This table details how cash moves in and out of Natural Alternatives International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	3.15	-0.15	-4.19	-0.43	-1.83	-1.49	1.95	1.71	-4.58	-3.99	5.44
Net Cash From Operating Activities	4.50	0.35	-3.62	-2.72	-3.44	0.04	5.99	3.35	-4.02	-6.33	2.50
Net Cash From Continuing Operating Activities	4.50	0.35	-3.62	-2.72	-3.44	0.04	5.99	3.35	-4.02	-6.33	2.50
Net Income / (Loss) Continuing Operations	-0.70	-3.07	-1.58	-1.87	-1.98	-2.19	-2.19	-7.22	-0.29	-2.55	-4.31
Consolidated Net Income / (Loss)	-0.70	-3.07	-1.58	-1.87	-1.98	-2.19	-2.19	-7.22	-0.29	-2.55	-4.31
Depreciation Expense	1.15	1.19	1.10	1.21	1.13	1.13	1.14	1.16	1.17	1.17	1.19
Non-Cash Adjustments To Reconcile Net Income	0.51	3.72	-1.87	1.97	2.11	-0.21	0.57	3.05	0.25	0.34	3.87
Changes in Operating Assets and Liabilities, net	3.54	-1.50	-1.28	-4.02	-4.70	1.30	6.47	6.35	-5.15	-5.28	1.75
Net Cash From Investing Activities	-1.28	-0.43	-0.28	-1.03	-0.30	-1.06	-0.80	-1.46	-1.03	-0.93	-1.10
Net Cash From Continuing Investing Activities	-1.28	-0.43	-0.28	-1.03	-0.30	-1.06	-0.80	-1.46	-1.03	-0.93	-1.10
Purchase of Property, Plant & Equipment	-1.28	-0.43	-0.28	-1.03	-0.30	-1.06	-0.80	-1.46	-1.03	-0.93	-1.10
Net Cash From Financing Activities	-0.07	-0.07	-0.29	3.33	1.92	-0.47	-3.24	-0.18	0.47	3.27	4.04
Net Cash From Continuing Financing Activities	-0.07	-0.07	-0.29	3.33	1.92	-0.47	-3.24	-0.18	0.47	3.27	4.04
Repayment of Debt	-0.07	-0.07	-0.07	-0.07	-0.07	-0.07	-0.08	-0.07	-0.07	-0.08	-0.08
Repurchase of Common Equity	0.00	-	-0.22	-0.00	-0.01	-	-0.17	-0.00	-0.01	-	-0.08
Issuance of Debt	0.00	-	-	3.40	2.00	-0.40	-3.00	-0.10	0.55	3.35	4.20
Cash Interest Paid	0.05	0.06	0.07	0.10	0.16	0.26	0.22	0.19	0.15	0.21	0.27
Cash Income Taxes Paid	0.25	0.02	0.01	0.18	0.00	0.35	0.01	-0.04	0.41	0.00	0.00

This table presents Natural Alternatives International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	54	74	73	85	93	120	120	146	134	162	152
Total Current Assets	44	56	52	65	71	79	80	77	57	62	59
Cash & Equivalents	19	20	28	24	25	30	32	22	14	12	12
Accounts Receivable	9.90	13	8.41	15	16	17	18	17	7.02	17	15
Inventories, net	13	21	14	24	26	28	27	32	30	24	25
Prepaid Expenses	1.91	2.14	1.46	1.83	1.50	2.28	2.17	1.81	6.00	8.00	6.79
Current Deferred & Refundable Income Taxes	0.68	0.01	0.26	0.00	0.90	0.85	1.10	0.07	0.31	0.00	0.28
Other Current Assets	-	-	-	0.06	1.98	0.45	0.00	3.14	0.39	0.49	0.37
Plant, Property, & Equipment, net	7.63	15	18	19	21	22	22	45	54	52	51
Total Noncurrent Assets	2.58	3.13	2.78	0.73	1.02	20	18	25	23	49	42
Other Noncurrent Operating Assets	0.92	0.90	0.77	0.73	1.02	19	17	25	23	45	42
Total Liabilities & Shareholders' Equity	54	74	73	85	93	120	120	146	134	162	152
Total Liabilities	9.96	20	11	17	17	49	40	57	45	80	84
Total Current Liabilities	9.09	19	10	14	14	28	22	24	16	23	29
Short-Term Debt	-	-	-	-	0.00	10	0.00	0.30	0.31	3.70	2.21
Accounts Payable	4.65	13	5.12	9.65	8.63	13	12	16	7.78	13	15
Accrued Expenses	2.50	2.24	2.35	2.35	2.78	1.57	2.44	2.79	2.41	2.85	3.11
Customer Deposits	-	-	-	-	-	-	1.72	0.14	0.32	0.30	1.36
Current Deferred & Payable Income Tax Liabilities	0.49	1.34	1.21	0.79	1.22	1.01	0.62	0.17	0.37	0.51	0.41
Current Employee Benefit Liabilities	1.46	2.80	1.59	1.50	1.62	2.66	4.58	3.67	2.25	2.09	2.17
Other Current Liabilities	-	-	-	-	-	0.00	0.81	0.63	2.45	1.29	4.19
Total Noncurrent Liabilities	0.86	1.24	1.19	2.68	3.16	21	18	34	29	56	55
Long-Term Debt	-	-	-	-	-	-	0.00	9.49	9.21	8.93	8.63
Noncurrent Employee Benefit Liabilities	0.44	0.76	0.56	0.05	0.25	0.70	0.39	0.34	0.34	0.14	0.11
Other Noncurrent Operating Liabilities	0.02	0.00	0.10	-	0.00	19	16	21	19	46	46
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	44	54	61	68	76	71	80	89	89	83	68
Total Preferred & Common Equity	44	54	61	68	76	71	80	89	89	83	68
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	44	54	61	68	76	71	80	89	89	83	68
Common Stock	20	21	22	25	26	28	30	31	32	33	34
Retained Earnings	29	39	46	51	57	56	67	78	80	73	59
Treasury Stock	-4.71	-5.36	-6.07	-6.58	-7.96	-12	-16	-21	-23	-23	-23
Accumulated Other Comprehensive Income / (Loss)	-0.77	-0.68	-0.91	-0.58	0.29	-1.18	-0.56	1.70	-0.08	-0.02	-1.42

This table presents Natural Alternatives International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	160	156	153	161	156	155	157	153	155
Total Current Assets	58	54	54	62	59	59	65	62	64
Cash & Equivalents	17	17	12	10	8.66	11	7.74	3.75	9.20
Accounts Receivable	9.75	10	11	18	17	12	19	18	21
Inventories, net	23	20	21	26	23	27	31	33	30
Prepaid Expenses	6.83	6.45	7.67	8.74	7.99	7.71	7.56	6.29	4.14
Current Deferred & Refundable Income Taxes	0.34	0.88	1.66	-	0.92	1.36	0.18	0.12	0.07
Other Current Assets	0.79	0.41	0.34	0.03	1.04	0.20	0.00	0.16	0.07
Plant, Property, & Equipment, net	54	53	52	51	51	51	51	51	51
Total Noncurrent Assets	49	48	46	48	47	46	41	41	40
Other Noncurrent Operating Assets	48	48	46	44	44	43	41	41	40
Total Liabilities & Shareholders' Equity	160	156	153	161	156	155	157	153	155
Total Liabilities	71	70	69	81	77	78	88	86	92
Total Current Liabilities	15	13	14	24	22	23	34	33	39
Short-Term Debt	0.29	0.29	0.29	5.70	5.30	2.30	2.76	6.11	10
Accounts Payable	7.61	7.49	6.97	9.95	8.60	13	20	17	18
Accrued Expenses	2.72	2.01	2.43	2.71	2.25	2.19	3.76	3.67	3.37
Customer Deposits	0.41	0.70	0.39	0.64	1.17	1.52	0.93	-	1.32
Current Deferred & Payable Income Tax Liabilities	0.20	0.00	0.00	0.09	0.00	0.00	0.00	0.00	0.00
Current Employee Benefit Liabilities	2.37	1.66	2.09	2.86	2.13	2.41	3.03	2.51	3.25
Other Current Liabilities	1.85	1.26	1.48	2.51	2.21	2.07	3.33	2.81	2.72
Total Noncurrent Liabilities	56	57	55	57	55	55	54	53	53
Long-Term Debt	9.15	9.08	9.01	8.86	8.78	8.70	8.55	8.47	8.39
Noncurrent Employee Benefit Liabilities	0.33	0.35	0.30	0.14	0.16	0.16	0.12	0.14	0.15
Other Noncurrent Operating Liabilities	46	47	45	47	46	45	45	45	44
Commitments & Contingencies	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	89	85	84	80	79	77	69	67	63
Total Preferred & Common Equity	89	85	84	80	79	77	69	67	63
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	89	85	84	80	79	77	69	67	63
Common Stock	32	32	32	33	33	34	34	34	34
Retained Earnings	79	76	75	71	69	67	59	57	52
Treasury Stock	-23	-23	-23	-23	-23	-23	-23	-23	-23
Accumulated Other Comprehensive Income / (Loss)	0.35	-0.24	-0.12	-0.72	0.15	-0.26	-0.70	-0.30	0.02

This table displays calculated financial ratios and metrics derived from Natural Alternatives International's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
DEI Shares Outstanding	6,839,974.00	6,868,627.00	6,938,352.00	7,558,409.00	7,258,647.00	6,788,366.00	6,418,978.00	6,150,452.00	6,077,213.00	3,280,037.00	6,178,898.00
DEI Adjusted Shares Outstanding	6,839,974.00	6,868,627.00	6,938,352.00	7,558,409.00	7,258,647.00	6,788,366.00	6,418,978.00	6,150,452.00	6,077,213.00	3,280,037.00	6,178,898.00
DEI Earnings Per Adjusted Shares Outstanding	0.49	1.39	1.04	0.67	0.90	-0.24	1.68	2.11	0.42	-2.20	-2.20
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.53%	43.63%	6.78%	8.60%	4.42%	-14.04%	50.17%	-4.23%	-9.91%	-26.11%	14.12%
EBITDA Growth	20.97%	126.56%	-20.85%	3.37%	-23.03%	-77.96%	685.41%	7.88%	-54.03%	-156.33%	-17.29%
EBIT Growth	61.93%	213.78%	-28.16%	-1.22%	-35.89%	-130.23%	762.45%	12.09%	-71.05%	-333.55%	-7.69%
NOPAT Growth	55.68%	166.84%	-19.48%	-34.65%	8.06%	-121.55%	1,249.47%	-11.65%	-68.83%	-278.67%	-1.48%
Net Income Growth	67.80%	185.30%	-24.21%	-30.19%	29.50%	-125.15%	754.59%	-0.52%	-76.46%	-386.16%	-88.10%
EPS Growth	68.97%	193.88%	-24.31%	-33.03%	26.03%	-127.17%	776.00%	2.96%	-75.29%	-386.05%	-85.37%
Operating Cash Flow Growth	-49.92%	246.71%	52.26%	-87.03%	258.10%	-43.77%	463.70%	-42.97%	-40.85%	-121.33%	496.26%
Free Cash Flow Firm Growth	-69.62%	-105.69%	15,896.65%	-189.19%	77.83%	35.52%	1,659.85%	-217.51%	72.71%	6.74%	326.11%
Invested Capital Growth	10.39%	34.26%	-1.98%	34.02%	14.36%	-0.17%	-5.90%	59.50%	10.73%	-1.70%	-19.59%
Revenue Q/Q Growth	1.79%	12.98%	-2.80%	5.60%	-6.08%	4.24%	5.49%	-0.71%	-4.51%	-5.33%	3.49%
EBITDA Q/Q Growth	-0.70%	26.23%	-16.45%	12.86%	-28.79%	416.97%	10.44%	21.83%	-29.90%	-557.71%	0.35%
EBIT Q/Q Growth	-1.38%	33.15%	-21.44%	17.28%	-40.28%	59.62%	14.20%	32.77%	-49.28%	-155.83%	0.67%
NOPAT Q/Q Growth	-3.70%	41.66%	-21.81%	26.81%	-36.53%	65.59%	9.01%	21.54%	-44.30%	-201.02%	6.29%
Net Income Q/Q Growth	-2.90%	34.56%	-20.87%	36.48%	-31.99%	54.76%	12.12%	28.56%	-56.72%	-118.30%	-64.89%
EPS Q/Q Growth	-3.92%	35.85%	-20.44%	32.73%	-32.85%	55.36%	12.67%	27.01%	-53.26%	-119.64%	-64.03%
Operating Cash Flow Q/Q Growth	-61.78%	230.66%	-4.42%	-83.28%	38.95%	-11.02%	43.23%	49.65%	-15.17%	-117.19%	4,663.08%
Free Cash Flow Firm Q/Q Growth	-78.11%	97.21%	58.35%	-219.64%	76.55%	14.39%	42.43%	9.18%	-105.90%	94.54%	511.41%
Invested Capital Q/Q Growth	-0.51%	2.19%	-10.76%	26.73%	3.39%	7.43%	0.03%	0.15%	0.00%	2.78%	-13.09%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	18.03%	22.12%	21.49%	19.87%	17.05%	15.87%	17.05%	17.85%	11.79%	6.03%	7.15%
EBITDA Margin	8.44%	13.32%	9.87%	9.40%	6.93%	1.78%	9.29%	10.46%	5.34%	-4.07%	-4.18%
Operating Margin	5.23%	10.73%	7.96%	7.20%	4.31%	-1.27%	7.66%	8.00%	3.06%	-7.50%	-6.67%
EBIT Margin	5.39%	11.77%	7.92%	7.20%	4.42%	-1.55%	6.86%	8.03%	2.58%	-8.15%	-7.70%
Profit (Net Income) Margin	4.21%	8.36%	5.93%	3.81%	4.73%	-1.38%	6.03%	6.27%	1.64%	-6.34%	-10.45%
Tax Burden Percent	77.69%	70.34%	71.56%	47.59%	82.25%	94.65%	88.81%	78.42%	70.94%	76.26%	126.40%
Interest Burden Percent	100.56%	100.99%	104.72%	111.28%	130.08%	94.05%	99.04%	99.54%	89.48%	101.99%	107.48%
Effective Tax Rate	22.31%	29.66%	28.44%	52.41%	17.75%	0.00%	11.19%	21.58%	29.06%	0.00%	0.00%
Return on Invested Capital (ROIC)	13.40%	29.08%	20.64%	11.64%	10.25%	-2.07%	24.55%	17.24%	4.15%	-7.11%	-8.07%
ROIC Less NNEP Spread (ROIC-NNEP)	12.79%	24.26%	19.41%	9.64%	3.51%	0.52%	29.78%	17.31%	14.34%	65.19%	1,772.26%
Return on Net Nonoperating Assets (RNNOA)	-5.64%	-9.52%	-8.04%	-3.84%	-1.18%	-0.16%	-10.33%	-4.54%	-1.30%	-1.31%	-9.90%
Return on Equity (ROE)	7.75%	19.56%	12.60%	7.81%	9.06%	-2.23%	14.22%	12.71%	2.85%	-8.42%	-17.98%
Cash Return on Invested Capital (CROIC)	3.52%	-0.16%	22.64%	-17.43%	-3.15%	-1.90%	30.64%	-28.62%	-6.03%	-5.40%	13.65%
Operating Return on Assets (OROA)	8.08%	21.00%	13.16%	12.09%	6.84%	-1.73%	10.18%	10.31%	2.84%	-6.26%	-6.36%
Return on Assets (ROA)	6.31%	14.92%	9.86%	6.40%	7.32%	-1.54%	8.96%	8.05%	1.80%	-4.87%	-8.64%
Return on Common Equity (ROCE)	7.75%	19.56%	12.60%	7.81%	9.06%	-2.23%	14.22%	12.71%	2.85%	-8.42%	-17.98%
Return on Equity Simple (ROE_SIMPLE)	7.63%	17.77%	11.83%	7.40%	8.60%	-2.30%	13.45%	12.10%	2.84%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	3.23	8.62	6.94	4.54	4.90	-1.06	12	11	3.34	-5.97	-6.06
NOPAT Margin	4.06%	7.55%	5.69%	3.43%	3.55%	-0.89%	6.80%	6.27%	2.17%	-5.25%	-4.67%
Net Nonoperating Expense Percent (NNEP)	0.60%	4.83%	1.23%	2.00%	6.73%	-2.59%	-5.23%	-0.07%	-10.19%	-72.30%	-1,780.33%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-6.27%	-7.65%
Cost of Revenue to Revenue	81.97%	77.88%	78.51%	80.13%	82.95%	84.13%	82.95%	82.08%	88.21%	93.97%	92.85%
SG&A Expenses to Revenue	12.80%	11.38%	13.53%	12.68%	12.74%	14.38%	9.47%	9.91%	9.65%	13.53%	12.74%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	12.80%	11.38%	13.53%	12.68%	12.74%	17.14%	9.39%	9.91%	8.73%	13.53%	13.82%
Earnings before Interest and Taxes (EBIT)	4.28	13	9.66	9.54	6.11	-1.85	12	14	3.97	-9.28	-9.99
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6.71	15	12	12	9.58	2.11	17	18	8.22	-4.63	-5.43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.88	1.41	1.13	1.12	1.11	0.65	1.35	0.73	0.49	0.24	0.30
Price to Tangible Book Value (P/TBV)	0.88	1.41	1.13	1.12	1.11	0.65	1.35	0.73	0.49	0.24	0.30
Price to Revenue (P/Rev)	0.49	0.66	0.57	0.58	0.61	0.39	0.61	0.38	0.28	0.17	0.16
Price to Earnings (P/E)	11.58	7.94	9.54	15.19	12.94	0.00	10.03	4.95	17.35	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	8.64%	12.59%	10.48%	6.58%	7.73%	0.00%	9.97%	20.20%	5.76%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.80	1.65	1.24	1.19	1.17	0.51	1.58	0.68	0.47	0.25	0.28
Enterprise Value to Revenue (EV/Rev)	0.25	0.49	0.34	0.40	0.43	0.22	0.43	0.31	0.26	0.18	0.14
Enterprise Value to EBITDA (EV/EBITDA)	3.01	3.69	3.42	4.27	6.22	12.29	4.58	2.92	4.82	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	4.72	4.17	4.27	5.57	9.75	0.00	6.20	3.80	9.98	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	6.25	6.50	5.93	11.70	12.16	0.00	6.25	4.86	11.86	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	7.54	6.04	2.91	28.97	9.08	7.03	3.65	4.40	5.65	0.00	3.17
Enterprise Value to Free Cash Flow (EV/FCFF)	23.82	0.00	5.41	0.00	0.00	0.00	5.01	0.00	0.00	0.00	1.83
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.14	0.00	0.11	0.11	0.15	0.16
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.11	0.10	0.11	0.13
Financial Leverage	-0.44	-0.39	-0.41	-0.40	-0.34	-0.31	-0.35	-0.26	-0.09	-0.02	-0.01
Leverage Ratio	1.23	1.31	1.28	1.22	1.24	1.45	1.59	1.58	1.58	1.73	2.08
Compound Leverage Factor	1.24	1.32	1.34	1.36	1.61	1.36	1.57	1.57	1.41	1.76	2.24
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	12.29%	0.00%	9.96%	9.68%	13.26%	13.67%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	12.29%	0.00%	0.31%	0.32%	3.88%	2.78%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9.66%	9.37%	9.38%	10.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	87.71%	100.00%	90.04%	90.32%	86.74%	86.33%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	4.74	0.00	0.55	1.16	-2.73	-1.99
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-9.70	0.00	-0.67	-0.50	-0.14	0.27
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.53	1.12	-1.93	-1.59
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-9.47	0.00	0.91	2.85	-2.11	-1.79
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	19.39	0.00	-1.12	-1.22	-0.11	0.25
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88	2.75	-1.50	-1.42
Altman Z-Score	5.60	5.68	7.30	6.19	6.21	2.67	4.79	3.33	3.03	1.57	1.57
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.79	2.91	5.03	4.56	5.01	2.84	3.64	3.21	3.59	2.63	2.06
Quick Ratio	3.13	1.72	3.53	2.78	2.88	1.71	2.27	1.64	1.30	1.23	0.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.85	-0.05	7.62	-6.79	-1.51	-0.97	15	-18	-4.86	-4.53	10
Operating Cash Flow to CapEx	165.51%	124.78%	265.28%	45.23%	123.66%	81.91%	412.90%	44.85%	52.12%	-49.62%	164.14%
Free Cash Flow to Firm to Interest Expense	70.67	0.00	2,538.78	-754.78	-51.94	-14.50	128.40	-214.51	-10.77	-12.55	11.20
Operating Cash Flow to Interest Expense	223.17	0.00	4,712.33	203.67	226.34	55.09	176.32	142.96	15.56	-4.15	6.48
Operating Cash Flow Less CapEx to Interest Expense	88.33	0.00	2,936.00	-246.67	43.31	-12.16	133.62	-175.81	-14.30	-12.50	2.53
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.50	1.78	1.66	1.68	1.55	1.11	1.48	1.28	1.10	0.77	0.83
Accounts Receivable Turnover	9.50	9.88	11.28	11.50	9.04	7.21	10.22	9.67	12.60	9.52	8.24
Inventory Turnover	5.13	5.34	5.55	5.69	4.63	3.71	5.39	4.72	4.37	3.96	4.91
Fixed Asset Turnover	9.67	10.02	7.32	7.08	6.85	5.58	8.15	5.12	3.13	2.15	2.52
Accounts Payable Turnover	11.78	10.18	10.68	14.37	12.55	9.46	12.14	10.00	11.34	10.42	8.58
Days Sales Outstanding (DSO)	38.40	36.93	32.37	31.74	40.36	50.61	35.73	37.75	28.96	38.35	44.32
Days Inventory Outstanding (DIO)	71.14	68.39	65.76	64.14	78.86	98.50	67.76	77.35	83.51	92.07	74.35
Days Payable Outstanding (DPO)	30.99	35.84	34.19	25.39	29.09	38.58	30.07	36.51	32.19	35.02	42.52
Cash Conversion Cycle (CCC)	78.56	69.49	63.93	70.49	90.14	110.52	73.41	78.59	80.29	95.40	76.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	25	34	33	45	51	51	48	76	85	83	67
Invested Capital Turnover	3.30	3.85	3.62	3.40	2.89	2.33	3.61	2.75	1.91	1.36	1.73
Increase / (Decrease) in Invested Capital	2.38	8.67	-0.67	11	6.41	-0.09	-3.01	29	8.20	-1.44	-16
Enterprise Value (EV)	20	56	41	53	60	26	76	52	40	20	19
Market Capitalization	39	76	69	77	85	46	108	64	44	20	20
Book Value per Share	$6.41	$7.82	$8.81	$9.03	$10.48	$10.51	$12.48	$14.39	$14.61	$25.18	$11.07
Tangible Book Value per Share	$6.41	$7.82	$8.81	$9.03	$10.48	$10.51	$12.48	$14.39	$14.61	$25.18	$11.07
Total Capital	44	54	61	68	76	81	80	98	98	95	79
Total Debt	0.00	0.00	0.00	0.00	0.00	10	0.00	9.80	9.52	13	11
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.49	9.21	8.93	8.63
Net Debt	-19	-20	-28	-24	-25	-20	-32	-12	-4.09	0.65	-1.49
Capital Expenditures (CapEx)	1.62	7.44	5.33	4.05	5.31	4.51	5.04	26	13	3.02	3.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)	16	17	14	27	32	31	26	31	28	30	20
Debt-free Net Working Capital (DFNWC)	35	37	41	51	57	61	58	53	41	42	33
Net Working Capital (NWC)	35	37	41	51	57	51	58	53	41	38	30
Net Nonoperating Expense (NNE)	-0.11	-0.92	-0.29	-0.51	-1.64	0.59	1.37	0.02	0.82	1.24	7.51
Net Nonoperating Obligations (NNO)	-19	-20	-28	-24	-25	-20	-32	-12	-4.09	0.65	-1.49
Total Depreciation and Amortization (D&A)	2.43	1.77	2.38	2.91	3.47	3.96	4.34	4.17	4.25	4.65	4.56
Debt-free, Cash-free Net Working Capital to Revenue	20.07%	14.82%	11.14%	20.61%	23.21%	25.86%	14.64%	18.32%	18.07%	26.24%	15.67%
Debt-free Net Working Capital to Revenue	43.40%	32.12%	33.97%	38.44%	41.32%	51.50%	32.64%	31.09%	26.91%	36.77%	25.16%
Net Working Capital to Revenue	43.40%	32.12%	33.97%	38.44%	41.32%	43.09%	32.64%	30.91%	26.70%	33.52%	23.47%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.50	$1.46	$1.10	$0.76	$0.96	($0.25)	$1.71	$1.75	$0.43	($1.23)	($2.28)
Adjusted Weighted Average Basic Shares Outstanding	6.75M	6.52M	6.58M	6.64M	6.81M	6.70M	6.29M	6.12M	5.86M	5.87M	5.95M
Adjusted Diluted Earnings per Share	$0.49	$1.44	$1.09	$0.73	$0.92	($0.25)	$1.69	$1.74	$0.43	($1.23)	($2.28)
Adjusted Weighted Average Diluted Shares Outstanding	6.81M	6.64M	6.66M	6.89M	7.10M	6.70M	6.38M	6.16M	5.88M	5.87M	5.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	6.71M	6.87M	7.44M	7.56M	7.23M	6.52M	6.43M	6.09M	6.09M	6.20M	6.18M
Normalized Net Operating Profit after Tax (NOPAT)	3.23	8.62	6.94	6.67	4.90	-1.06	12	11	3.34	-5.97	-5.08
Normalized NOPAT Margin	4.06%	7.55%	5.69%	5.04%	3.55%	-0.89%	6.80%	6.27%	2.17%	-5.25%	-3.91%
Pre Tax Income Margin	5.42%	11.88%	8.29%	8.01%	5.75%	-1.46%	6.79%	7.99%	2.31%	-8.32%	-8.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	356.92	0.00	3,218.33	1,059.67	210.83	-27.58	103.75	165.33	8.81	-25.70	-10.92
NOPAT to Interest Expense	269.25	0.00	2,314.11	504.11	169.06	-15.77	102.90	129.25	7.41	-16.55	-6.63
EBIT Less CapEx to Interest Expense	222.08	0.00	1,442.00	609.33	27.79	-94.84	61.04	-153.45	-21.05	-34.06	-14.87
NOPAT Less CapEx to Interest Expense	134.42	0.00	537.78	53.78	-13.98	-83.02	60.19	-189.52	-22.45	-24.91	-10.57
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	60.40%	6.79%	9.84%	10.10%	20.90%	-227.78%	38.51%	51.37%	59.60%	-3.06%	-1.31%

This table displays calculated financial ratios and metrics derived from Natural Alternatives International's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	6,088,813.00	6,088,813.00	6,088,813.00	3,280,037.00	6,198,778.00	12,397,556.00	6,198,778.00	6,178,898.00	6,176,778.00	-	6,176,778.00
DEI Adjusted Shares Outstanding	6,088,813.00	6,088,813.00	6,088,813.00	3,280,037.00	6,198,778.00	12,397,556.00	6,198,778.00	6,178,898.00	6,176,778.00	-	6,176,778.00
DEI Earnings Per Adjusted Shares Outstanding	-0.11	-0.50	-0.24	-0.61	-0.32	-0.18	-0.35	-1.17	-0.05	-	-0.70
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-21.24%	-40.41%	-23.13%	-17.84%	-2.41%	35.22%	14.44%	14.84%	13.82%	2.10%	23.35%
EBITDA Growth	-85.16%	-175.58%	46.74%	-136.46%	-427.87%	42.08%	-46.80%	1.26%	201.93%	37.19%	-112.46%
EBIT Growth	-157.60%	-261.84%	25.89%	-192.51%	-183.50%	30.34%	-23.03%	2.47%	99.87%	19.93%	-62.36%
NOPAT Growth	-130.91%	-224.78%	21.54%	-174.88%	-237.50%	20.87%	-7.58%	23.01%	115.47%	33.56%	-91.14%
Net Income Growth	-166.00%	-269.33%	33.73%	-192.00%	-185.18%	28.63%	-38.53%	-285.06%	85.32%	-16.52%	-97.21%
EPS Growth	-166.67%	-267.74%	34.15%	-191.43%	-175.00%	28.85%	-37.04%	-278.13%	84.85%	-13.51%	-94.59%
Operating Cash Flow Growth	198.60%	-95.80%	13.82%	-136.28%	-176.58%	-89.37%	265.37%	223.11%	-16.85%	-17,208.11%	-58.23%
Free Cash Flow Firm Growth	-189.13%	-191.29%	-210.37%	94.43%	94.68%	89.74%	103.05%	4,692.38%	379.73%	165.15%	-36.71%
Invested Capital Growth	0.00%	0.00%	0.00%	-1.70%	3.77%	8.09%	-4.91%	-19.59%	-14.18%	-7.90%	-5.71%
Revenue Q/Q Growth	-5.36%	-25.81%	-0.26%	17.32%	12.41%	2.80%	-15.59%	17.73%	11.41%	-7.78%	1.97%
EBITDA Q/Q Growth	-91.59%	-841.67%	65.48%	-69.25%	24.34%	-31.03%	12.51%	-13.84%	178.11%	-180.74%	-195.95%
EBIT Q/Q Growth	-127.25%	-371.75%	47.30%	-36.55%	16.49%	-15.92%	6.92%	-8.26%	99.89%	-70,066.67%	-88.74%
NOPAT Q/Q Growth	-116.13%	-545.77%	44.44%	-29.35%	27.29%	-51.42%	24.46%	7.43%	114.61%	-750.35%	-117.33%
Net Income Q/Q Growth	-134.12%	-341.73%	48.60%	-18.76%	-5.76%	-10.54%	0.23%	-230.10%	95.97%	-777.32%	-68.86%
EPS Q/Q Growth	-134.29%	-333.33%	48.08%	-18.52%	-3.13%	-12.12%	0.00%	-227.03%	95.87%	-740.00%	-71.43%
Operating Cash Flow Q/Q Growth	-39.97%	-92.26%	-1,141.38%	25.03%	-26.72%	101.07%	16,097.30%	-44.18%	-220.27%	-57.35%	139.54%
Free Cash Flow Firm Q/Q Growth	-1,301.64%	1.47%	-2.07%	99.60%	-1,239.54%	-89.78%	130.31%	496.02%	-18.41%	-55.80%	-70.56%
Invested Capital Q/Q Growth	-3.75%	-4.02%	3.53%	2.78%	1.61%	-0.03%	-8.92%	-13.09%	8.45%	7.29%	-6.75%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.23%	1.54%	7.65%	4.81%	6.81%	4.90%	6.35%	10.44%	11.65%	7.16%	1.08%
EBITDA Margin	1.02%	-10.24%	-3.54%	-5.11%	-3.44%	-4.39%	-4.55%	-4.40%	3.08%	-2.70%	-7.83%
Operating Margin	-1.60%	-13.94%	-7.77%	-8.56%	-5.54%	-8.16%	-7.30%	-5.74%	0.75%	-5.31%	-11.31%
EBIT Margin	-2.36%	-14.98%	-7.91%	-9.21%	-6.84%	-7.71%	-8.51%	-7.82%	-0.01%	-6.05%	-11.20%
Profit (Net Income) Margin	-2.05%	-12.18%	-6.28%	-6.35%	-5.98%	-6.43%	-7.60%	-21.31%	-0.77%	-7.34%	-12.15%
Tax Burden Percent	78.62%	80.14%	80.18%	67.39%	82.14%	76.45%	82.74%	255.98%	146.23%	109.62%	101.60%
Interest Burden Percent	110.50%	101.51%	98.94%	102.39%	106.39%	109.01%	107.97%	106.42%	6,633.33%	110.64%	106.80%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-3.98%	-31.87%	-16.14%	-8.12%	-5.27%	-8.55%	-8.12%	-6.95%	0.90%	-6.18%	-15.02%
ROIC Less NNEP Spread (ROIC-NNEP)	4.62%	-14.96%	-2.51%	-1.93%	42.70%	18.60%	44.72%	1,380.54%	-11.40%	-21.69%	-45.33%
Return on Net Nonoperating Assets (RNNOA)	-0.38%	1.26%	0.09%	0.04%	-0.73%	-0.20%	-0.75%	-7.72%	-0.61%	-2.41%	-3.21%
Return on Equity (ROE)	-4.36%	-30.61%	-16.04%	-8.08%	-6.01%	-8.75%	-8.87%	-14.66%	0.29%	-8.59%	-18.23%
Cash Return on Invested Capital (CROIC)	-196.31%	-206.03%	-204.90%	-5.40%	-11.98%	-15.60%	-3.15%	13.65%	9.44%	3.40%	-1.16%
Operating Return on Assets (OROA)	-2.13%	-12.29%	-6.21%	-7.07%	-4.81%	-6.03%	-6.93%	-6.46%	-0.01%	-5.29%	-10.25%
Return on Assets (ROA)	-1.85%	-9.99%	-4.93%	-4.88%	-4.20%	-5.02%	-6.19%	-17.61%	-0.65%	-6.41%	-11.13%
Return on Common Equity (ROCE)	-4.36%	-30.61%	-16.04%	-8.08%	-6.01%	-8.75%	-8.87%	-14.66%	0.29%	-8.59%	-18.23%
Return on Equity Simple (ROE_SIMPLE)	0.87%	-4.81%	-3.93%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.38	-2.46	-1.37	-1.77	-1.29	-1.95	-1.47	-1.36	0.20	-1.29	-2.81
NOPAT Margin	-1.12%	-9.76%	-5.44%	-5.99%	-3.88%	-5.71%	-5.11%	-4.02%	0.53%	-3.72%	-7.92%
Net Nonoperating Expense Percent (NNEP)	-8.60%	-16.91%	-13.63%	-6.19%	-47.97%	-27.15%	-52.84%	-1,387.49%	12.30%	15.51%	30.32%
Return On Investment Capital (ROIC_SIMPLE)	-	-2.59%	-1.46%	-1.86%	-1.36%	-2.09%	-1.68%	-1.72%	0.25%	-1.58%	-3.43%
Cost of Revenue to Revenue	90.77%	98.46%	92.35%	95.19%	93.19%	95.10%	93.65%	89.56%	88.35%	92.84%	98.92%
SG&A Expenses to Revenue	10.84%	15.48%	15.41%	13.37%	12.35%	13.06%	13.65%	12.04%	10.90%	12.47%	12.39%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	10.84%	15.48%	15.41%	13.37%	12.35%	13.06%	13.65%	16.18%	10.90%	12.47%	12.39%
Earnings before Interest and Taxes (EBIT)	-0.80	-3.77	-1.99	-2.72	-2.27	-2.63	-2.45	-2.65	-0.00	-2.11	-3.97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.35	-2.58	-0.89	-1.51	-1.14	-1.50	-1.31	-1.49	1.16	-0.94	-2.78
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.44	0.47	0.44	0.24	0.44	0.34	0.28	0.30	0.26	0.33	0.26
Price to Tangible Book Value (P/TBV)	0.44	0.47	0.44	0.24	0.44	0.34	0.28	0.30	0.26	0.33	0.26
Price to Revenue (P/Rev)	0.27	0.31	0.31	0.17	0.31	0.22	0.17	0.16	0.13	0.16	0.11
Price to Earnings (P/E)	51.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.96%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.40	0.42	0.42	0.25	0.47	0.38	0.28	0.28	0.29	0.42	0.35
Enterprise Value to Revenue (EV/Rev)	0.22	0.25	0.28	0.18	0.35	0.26	0.17	0.14	0.16	0.24	0.18
Enterprise Value to EBITDA (EV/EBITDA)	5.17	141.46	33.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	18.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	21.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	2.00	4.00	3.90	0.00	0.00	0.00	0.00	3.17	3.96	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.83	2.86	11.94	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.11	0.11	0.11	0.15	0.18	0.18	0.14	0.16	0.16	0.22	0.30
Long-Term Debt to Equity	0.10	0.11	0.11	0.11	0.11	0.11	0.11	0.13	0.12	0.13	0.13
Financial Leverage	-0.08	-0.08	-0.04	-0.02	-0.02	-0.01	-0.02	-0.01	0.05	0.11	0.07
Leverage Ratio	1.80	1.82	1.82	1.73	1.90	1.89	1.92	2.08	2.13	2.12	2.22
Compound Leverage Factor	1.99	1.85	1.80	1.77	2.02	2.07	2.07	2.21	141.47	2.34	2.37
Debt to Total Capital	9.61%	9.88%	9.96%	13.26%	15.36%	15.11%	12.56%	13.67%	14.08%	17.87%	22.86%
Short-Term Debt to Total Capital	0.30%	0.31%	0.31%	3.88%	6.01%	5.69%	2.63%	2.78%	3.43%	7.49%	12.60%
Long-Term Debt to Total Capital	9.32%	9.57%	9.64%	9.38%	9.35%	9.42%	9.93%	10.89%	10.64%	10.38%	10.26%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	90.39%	90.12%	90.04%	86.74%	84.64%	84.89%	87.44%	86.33%	85.92%	82.14%	77.14%
Debt to EBITDA	1.52	40.74	9.19	-2.73	-2.38	-2.80	-2.02	-1.99	-3.61	-5.67	-4.63
Net Debt to EBITDA	-1.17	-31.41	-3.07	-0.14	-0.72	-1.08	-0.07	0.27	-1.14	-4.21	-2.35
Long-Term Debt to EBITDA	1.47	39.47	8.90	-1.93	-1.45	-1.74	-1.60	-1.59	-2.73	-3.29	-2.08
Debt to NOPAT	6.28	-3.97	-4.69	-2.11	-2.12	-2.21	-1.70	-1.79	-2.47	-3.72	-3.55
Net Debt to NOPAT	-4.86	3.06	1.57	-0.11	-0.64	-0.85	-0.06	0.25	-0.78	-2.76	-1.81
Long-Term Debt to NOPAT	6.09	-3.85	-4.54	-1.50	-1.29	-1.38	-1.35	-1.42	-1.87	-2.16	-1.59
Altman Z-Score	2.23	2.08	2.07	1.71	1.82	1.83	1.80	1.73	1.74	1.73	1.60
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.74	4.06	3.98	2.63	2.56	2.70	2.51	2.06	1.92	1.87	1.64
Quick Ratio	1.72	2.02	1.73	1.23	1.14	1.18	0.95	0.94	0.79	0.66	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-82	-81	-82	-0.33	-4.36	-8.28	2.51	15	12	5.39	1.59
Operating Cash Flow to CapEx	351.80%	81.12%	-1,313.04%	-262.77%	-1,143.85%	3.50%	747.26%	229.90%	-390.58%	-677.73%	227.55%
Free Cash Flow to Firm to Interest Expense	-880.55	-1,152.72	-1,112.96	-2.63	-24.50	-29.77	10.20	70.18	53.97	24.07	5.88
Operating Cash Flow to Interest Expense	48.34	4.97	-48.97	-21.91	-19.34	0.13	24.36	15.70	-17.80	-28.26	9.27
Operating Cash Flow Less CapEx to Interest Expense	34.60	-1.16	-52.70	-30.25	-21.03	-3.67	21.10	8.87	-22.36	-32.43	5.20
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.90	0.82	0.78	0.77	0.70	0.78	0.81	0.83	0.85	0.87	0.92
Accounts Receivable Turnover	14.86	12.22	10.71	9.52	8.25	8.91	10.97	8.24	7.36	7.80	8.80
Inventory Turnover	5.53	6.00	5.20	3.96	4.35	5.38	4.92	4.91	4.35	4.35	4.60
Fixed Asset Turnover	2.68	2.40	2.29	2.15	2.15	2.34	2.44	2.52	2.64	2.65	2.80
Accounts Payable Turnover	16.93	15.70	15.72	10.42	12.19	14.24	11.96	8.58	8.19	9.78	8.46
Days Sales Outstanding (DSO)	24.57	29.87	34.07	38.35	44.22	40.97	33.26	44.32	49.60	46.80	41.47
Days Inventory Outstanding (DIO)	65.97	60.79	70.20	92.07	83.98	67.90	74.14	74.35	83.94	83.85	79.26
Days Payable Outstanding (DPO)	21.55	23.25	23.22	35.02	29.95	25.63	30.53	42.52	44.57	37.33	43.13
Cash Conversion Cycle (CCC)	68.99	67.41	81.05	95.40	98.24	83.24	76.87	76.15	88.97	93.32	77.60
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	82	78	81	83	85	85	77	67	73	78	73
Invested Capital Turnover	3.55	3.27	2.97	1.36	1.36	1.50	1.59	1.73	1.71	1.66	1.90
Increase / (Decrease) in Invested Capital	82	78	81	-1.44	3.08	6.33	-3.98	-16	-12	-6.68	-4.40
Enterprise Value (EV)	32	33	34	20	40	32	22	19	21	33	26
Market Capitalization	40	40	37	20	36	27	21	20	18	22	16
Book Value per Share	$14.59	$14.03	$13.81	$25.18	$12.94	$12.77	$12.36	$11.07	$11.17	$10.85	$10.22
Tangible Book Value per Share	$14.59	$14.03	$13.81	$25.18	$12.94	$12.77	$12.36	$11.07	$11.17	$10.85	$10.22
Total Capital	98	95	93	95	95	93	88	79	80	82	82
Total Debt	9.44	9.37	9.30	13	15	14	11	11	11	15	19
Total Long-Term Debt	9.15	9.08	9.01	8.93	8.86	8.78	8.70	8.63	8.55	8.47	8.39
Net Debt	-7.31	-7.22	-3.11	0.65	4.40	5.42	0.40	-1.49	3.57	11	9.51
Capital Expenditures (CapEx)	1.28	0.43	0.28	1.03	0.30	1.06	0.80	1.46	1.03	0.93	1.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	26	25	29	30	34	34	27	20	26	31	26
Debt-free Net Working Capital (DFNWC)	43	41	41	42	44	42	38	33	34	35	35
Net Working Capital (NWC)	42	41	41	38	38	37	35	30	31	29	25
Net Nonoperating Expense (NNE)	0.31	0.61	0.21	0.11	0.70	0.25	0.72	5.86	0.49	1.26	1.50
Net Nonoperating Obligations (NNO)	-7.31	-7.22	-3.11	0.65	4.40	5.42	0.40	-1.49	3.57	11	9.51
Total Depreciation and Amortization (D&A)	1.15	1.19	1.10	1.21	1.13	1.13	1.14	1.16	1.17	1.17	1.19
Debt-free, Cash-free Net Working Capital to Revenue	17.85%	19.32%	23.79%	26.24%	29.73%	27.52%	21.44%	15.67%	19.46%	22.96%	18.32%
Debt-free Net Working Capital to Revenue	29.41%	32.30%	34.12%	36.77%	38.72%	34.63%	29.89%	25.16%	25.22%	25.73%	24.80%
Net Working Capital to Revenue	29.21%	32.08%	33.87%	33.52%	33.68%	30.28%	28.06%	23.47%	23.17%	21.21%	17.53%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.12)	($0.52)	($0.27)	($0.32)	$0.00	($0.37)	($0.37)	($1.21)	($0.05)	($0.42)	($0.72)
Adjusted Weighted Average Basic Shares Outstanding	5.85M	5.85M	5.87M	5.87M	0.00	5.92M	5.94M	5.95M	6.01M	6.01M	6.03M
Adjusted Diluted Earnings per Share	($0.12)	($0.52)	($0.27)	($0.32)	$0.00	($0.37)	($0.37)	($1.21)	($0.05)	($0.42)	($0.72)
Adjusted Weighted Average Diluted Shares Outstanding	5.85M	5.85M	5.87M	5.87M	0.00	5.92M	5.94M	5.95M	6.01M	6.01M	6.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	6.09M	6.09M	3.28M	6.20M	0.00	6.20M	6.18M	6.18M	6.18M	6.18M	6.28M
Normalized Net Operating Profit after Tax (NOPAT)	-0.38	-2.46	-1.37	-1.77	-1.29	-1.95	-1.47	-1.36	0.20	-1.29	-2.81
Normalized NOPAT Margin	-1.12%	-9.76%	-5.44%	-5.99%	-3.88%	-5.71%	-5.11%	-4.02%	0.53%	-3.72%	-7.92%
Pre Tax Income Margin	-2.60%	-15.20%	-7.83%	-9.43%	-7.28%	-8.41%	-9.18%	-8.32%	-0.53%	-6.69%	-11.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-8.60	-53.91	-26.88	-21.90	-12.74	-9.46	-9.95	-12.44	-0.01	-9.40	-14.71
NOPAT to Interest Expense	-4.09	-35.13	-18.46	-14.25	-7.22	-7.00	-5.98	-6.39	0.88	-5.77	-10.41
EBIT Less CapEx to Interest Expense	-22.34	-60.04	-30.61	-30.24	-14.43	-13.26	-13.21	-19.27	-4.57	-13.57	-18.79
NOPAT Less CapEx to Interest Expense	-17.84	-41.26	-22.19	-22.59	-8.91	-10.80	-9.24	-13.22	-3.68	-9.94	-14.48
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	129.97%	-10.81%	-6.56%	-3.06%	-2.69%	-3.00%	-2.19%	-1.31%	-1.47%	-1.43%	-0.62%

Financials Breakdown Chart

Natural Alternatives International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Natural Alternatives International's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

Natural Alternatives International's net income appears to be on a downward trend, with a most recent value of -$13.58 million in 2025, falling from $3.35 million in 2015. The previous period was -$7.22 million in 2024. Find out what analysts predict for Natural Alternatives International in the coming months.

Natural Alternatives International's total operating income in 2025 was -$8.66 million, based on the following breakdown:

Total Gross Profit: $9.29 million
Total Operating Expenses: $17.95 million

Over the last 10 years, Natural Alternatives International's total revenue changed from $79.51 million in 2015 to $129.86 million in 2025, a change of 63.3%.

Natural Alternatives International's total liabilities were at $83.51 million at the end of 2025, a 4.7% increase from 2024, and a 738.8% increase since 2015.

In the past 10 years, Natural Alternatives International's cash and equivalents has ranged from $11.98 million in 2024 to $32.13 million in 2021, and is currently $12.33 million as of their latest financial filing in 2025.

Over the last 10 years, Natural Alternatives International's book value per share changed from 6.41 in 2015 to 11.07 in 2025, a change of 72.7%.

Related Companies

Financial statements for NASDAQ:NAII last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Natural Alternatives International (NAII) Financials

Financials Breakdown Chart

Natural Alternatives International Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Natural Alternatives International (NAII) Financials

Annual Income Statements for Natural Alternatives International

Quarterly Income Statements for Natural Alternatives International

Annual Cash Flow Statements for Natural Alternatives International

Quarterly Cash Flow Statements for Natural Alternatives International

Annual Balance Sheets for Natural Alternatives International

Quarterly Balance Sheets for Natural Alternatives International

Annual Metrics And Ratios for Natural Alternatives International

Quarterly Metrics And Ratios for Natural Alternatives International

Financials Breakdown Chart

Natural Alternatives International Financials - Frequently Asked Questions

When does Natural Alternatives International's financial year end?

How has Natural Alternatives International's net income changed over the last 10 years?

What is Natural Alternatives International's operating income?

How has Natural Alternatives International's revenue changed over the last 10 years?

How much debt does Natural Alternatives International have?

How much cash does Natural Alternatives International have?

How has Natural Alternatives International's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools